If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

UNITED States President Donald Trump’s imposition of 25% tariffs on all Canadian exports to the US cannot be justified by the ...

Lawmakers on Capitol Hill are considering permanently classifying fentanyl-related substances as Schedule 1 drugs, a move ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Discover how Trump's tariffs on Mexico, Canada, and China aim to combat fentanyl trafficking, with countries responding ...

Both Canada and Mexico have agreed to bolster border security, with Justin Trudeau agreeing to deploy 10,000 personnel to the ...

Older Black men account for a growing share of Milwaukee drug deaths as fentanyl creeps into cocaine supplies, catching a ...

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management.